NCT06952816 Validation Study of the EMILY AI Device in Acute and Chronic Respiratory Failure
| NCT ID | NCT06952816 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Aether Tech S.L. |
| Condition | Chronic Respiratory Failure |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-04-23 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-04-23 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Currently, there is no holistic solution for patients with respiratory diseases that includes oxygenation and management of a patient with respiratory disease, combining dynamic and automatic O2 administration and the detection of clinical worsening, generating a diagnostic suspicion, a management proposal, and notifying the medical team. For device validation, prospective studies will be conducted in patients in respiratory intermediate care units, conventional hospitalization, during physical activity in the hospital setting, and in an out-of-hospital setting. The device will be evaluated in terms of oxygenation efficacy, response time, patient safety, efficiency, versatility, clinical benefit, and adaptability.
Eligibility Criteria
Inclusion Criteria: * Men and women over 18 years of age. * Admitted to intermediate respiratory care unit with a diagnosis of acute respiratory failure for at least 8 hours. * Informed consent understood and signed. Exclusion Criteria: * Hemodynamic instability. * Severe temperature changes. * Hemoglobinopathies, severe anemia, severe acidosis, or severe alkalosis. * Anatomical disturbances. * Pregnancy or breastfeeding.
Frequently Asked Questions
Who can join the NCT06952816 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Respiratory Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06952816 currently recruiting?
Yes, NCT06952816 is actively recruiting participants. Visit ClinicalTrials.gov or contact Aether Tech S.L. to inquire about joining.
Where is the NCT06952816 trial being conducted?
This trial is being conducted at Madrid, Spain, Madrid, Spain.
Who is sponsoring the NCT06952816 clinical trial?
NCT06952816 is sponsored by Aether Tech S.L.. The trial plans to enroll 20 participants.